1. Home
  2. QMCO vs PMN Comparison

QMCO vs PMN Comparison

Compare QMCO & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Corporation

QMCO

Quantum Corporation

HOLD

Current Price

$10.79

Market Cap

129.1M

Sector

Technology

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$11.40

Market Cap

136.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QMCO
PMN
Founded
1980
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Electronic Components
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.1M
136.2M
IPO Year
2025
2022

Fundamental Metrics

Financial Performance
Metric
QMCO
PMN
Price
$10.79
$11.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$10.50
$42.67
AVG Volume (30 Days)
779.5K
108.4K
Earning Date
02-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
64.34
N/A
EPS
N/A
N/A
Revenue
$372,827,000.00
N/A
Revenue This Year
$0.32
N/A
Revenue Next Year
$8.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.65
N/A
52 Week Low
$4.19
$0.29
52 Week High
$18.48
$27.40

Technical Indicators

Market Signals
Indicator
QMCO
PMN
Relative Strength Index (RSI) 48.01 41.89
Support Level $9.25 $9.87
Resistance Level $11.28 $14.40
Average True Range (ATR) 0.89 1.41
MACD 0.09 -0.34
Stochastic Oscillator 54.56 4.42

Price Performance

Historical Comparison
QMCO
PMN

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

Share on Social Networks: